Divi's Laboratories Limited FII & DII Activity
5-Day Flow Trend
| Date | FII Net (₹ Cr) | DII Net (₹ Cr) |
|---|---|---|
| 2026-10-28 | +871.83 | +643.35 |
| 2026-10-27 | −1462.49 | +2609.57 |
| 2026-10-26 | −1462.49 | +2609.57 |
| 2026-10-23 | +887.65 | +3235.36 |
| 2026-10-22 | −3458.70 | +2891.32 |
Today's Institutional Flow
Dividends Laboratories Limited sees a net inflow of ₹871.83 crore from foreign institutional investors (FII) in cash transactions today, while domestic institutional investors (DII) add a further ₹643.35 crore. The combined cash injection of roughly ₹1.515 trillion underscores a bullish sentiment from both foreign and domestic money‑flows. No block or bulk trades are reported for the stock, indicating that the accumulation is occurring through regular market participation rather than large discrete blocks.
Trend vs 5‑Day Average
The day’s FII cash flow of +₹871.83 crore stands in stark contrast to the five‑day average net outflow of ₹‑894.74 crore, highlighting a pronounced reversal toward buying pressure. Conversely, DII activity remains comfortably above its five‑day average of +₹2,592.03 crore, reinforcing the sustained domestic enthusiasm that has persisted over the past week.
F&O Positioning Data
Foreign investors hold a net long position of ₹643,395 crore in F&O contracts on Dividends Laboratories, reflecting significant speculative or hedging interest. The index futures ratio of 1.2 indicates that FII long positions outweigh short positions by 20 percent, suggesting a mildly bullish bias in the broader market outlook.
Healthcare Sector Flow
Across the healthcare sector, recent weeks have witnessed a steady accumulation by both FIIs and DIIs, with foreign money turning net buyers after a period of modest outflows, while domestic institutions continue to add to their long positions.
Market-wide FII/DII data — same for all F&O stocks. Date: 2026-10-28